Biomerica, Inc.
BMRANASDAQHealthcareMedical Devices

About Biomerica

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company’s diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Company Information

CEOZackary Irani
Founded1971
Employees54
CountryUnited States
Fiscal YearJune - May

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone949 645 2111
Address
17571 Von Karman Avenue Irvine, California 92614 United States

Corporate Identifiers

CIK0000073290
CUSIP09061H406
ISINUS09061H4065
EIN95-2645573
SIC2835

Leadership Team & Key Executives

Zackary S. Irani
Chief Executive Officer and Director
Allen C. Barbieri
Executive Vice-Chairman of the Board and Corporate Secretary
Gary Lu CPA
Principal Accounting Officer and Chief Financial Officer
Lucy Liu Ph.D.
Director of Manufacturing and Technical Operations
Scott Madel
Chief Commercial Officer